Literature DB >> 18690416

Oxidative stress in migraine with and without aura.

Deniz Tuncel1, Fatma Inanc Tolun, Mustafa Gokce, Seçil Imrek, Hasan Ekerbiçer.   

Abstract

Migraine is the most common neurological disorder, but the molecular basis is still not completely understood. An impairment of mitochondrial oxidative metabolism might play a role in the pathophysiology. The goal of this study was to investigate the differences in oxidative stress status with the measurement of erythrocyte superoxide dismutase (SOD), catalase activity, and malondialdehyde (MDA) levels in the migraine patients with or without aura and attack. There were 56 patients (46 female, 10 male) in the migraine group and 25 matched healthy subjects in the control group. The patients comprised 37 with migraine without aura (MWoA], 19 with migraine with aura (MWA), and 22 with headache attack. The MDA levels of patients in the migraine group were significantly higher than that in the control group. The SOD activity was significantly higher in the MWA as compared to MWoA. There was no significant correlation between these levels and headache attack period. Conclusively, in this preliminary study, we had found increased oxidative stress in the migraine patients especially the patients with MWA. Further knowledge about this issue may contribute the cause and complications of migraine and may be essential for development of treatment approaches.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18690416     DOI: 10.1007/s12011-008-8193-9

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  23 in total

1.  Is SOD2 Ala16Val polymorphism associated with migraine with aura phenotype?

Authors:  Raffaele Palmirotta; Piero Barbanti; Maria Laura De Marchis; Gabriella Egeo; Cinzia Aurilia; Luisa Fofi; Cristiano Ialongo; Maria Giovanna Valente; Patrizia Ferroni; David Della-Morte; Fiorella Guadagni
Journal:  Antioxid Redox Signal       Date:  2014-11-11       Impact factor: 8.401

2.  Paraoxonase 1 (PON1) polymorphisms and risk for migraine.

Authors:  Elena García-Martín; Carmen Martínez; Mercedes Serrador; Hortensia Alonso-Navarro; Francisco Navacerrada; José A G Agúndez; Félix Javier Jiménez-Jiménez
Journal:  J Neurol       Date:  2010-04-21       Impact factor: 4.849

Review 3.  Riboflavin in Neurological Diseases: A Narrative Review.

Authors:  Domenico Plantone; Matteo Pardini; Giuseppe Rinaldi
Journal:  Clin Drug Investig       Date:  2021-04-22       Impact factor: 2.859

4.  Spreading depression transiently disrupts myelin via interferon-gamma signaling.

Authors:  Aya D Pusic; Heidi M Mitchell; Phillip E Kunkler; Neal Klauer; Richard P Kraig
Journal:  Exp Neurol       Date:  2014-12-08       Impact factor: 5.330

5.  Vitamin D in migraine headache: a comprehensive review on literature.

Authors:  Zeinab Ghorbani; Mansoureh Togha; Pegah Rafiee; Zeynab Sadat Ahmadi; Reyhaneh Rasekh Magham; Samane Haghighi; Soodeh Razeghi Jahromi; Maryam Mahmoudi
Journal:  Neurol Sci       Date:  2019-08-03       Impact factor: 3.307

6.  Efficacy of combined topiramate/thioctic acid therapy in migraine prophylaxis.

Authors:  Ahmed M Ali; Thanaa G Awad; Nagwa M Al-Adl
Journal:  Saudi Pharm J       Date:  2010-07-30       Impact factor: 4.330

7.  Evaluation of serum uric levels in migraine.

Authors:  Tamer Yazar; Hülya Olgun Yazar; Ali Aygün; Volkan Karabacak; Yavuz Altunkaynak; Dursun Kirbaş
Journal:  Neurol Sci       Date:  2020-07-20       Impact factor: 3.307

8.  Decreased antioxidant status in migraine patients with brain white matter hyperintensities.

Authors:  Bilal Aytaç; Özlem Coşkun; Bülent Alioğlu; Zahide Esra Durak; Süleyman Büber; Esra Tapçi; Ruhşen Ocal; Levent Ertuğrul Inan; İlker Durak; Tahir Kurtuluş Yoldaş
Journal:  Neurol Sci       Date:  2014-07-10       Impact factor: 3.307

9.  Role of endothelial cells in antihyperalgesia induced by a triptan and β-blocker.

Authors:  E K Joseph; J D Levine
Journal:  Neuroscience       Date:  2012-12-20       Impact factor: 3.590

Review 10.  The metabolic face of migraine - from pathophysiology to treatment.

Authors:  Elena C Gross; Marco Lisicki; Dirk Fischer; Peter S Sándor; Jean Schoenen
Journal:  Nat Rev Neurol       Date:  2019-10-04       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.